PURPOSE: We aimed to observe the effects and mechanism of rhBNP treatment on myocardial fibrosis (MF) after myocardial infarction (MI). METHODS: SPF rats were separated into 3 groups: normal, MI (ligation of left coronary artery), and MI + rhBNP (recombinant human brain natriuretic peptide). Rats in MI + rhBNP group were given 30 μg/kg for 2 days before modeling and for 4 weeks after modeling. mRNA levels and the expression levels of TGF-β1 (transforming growth factor) and CTGF (connective tissue growth factor) in 3 groups were analyzed using the RT-qPCR and western blotting analysis, respectively. Furthermore, myocardial volume fraction (CVF) was analyzed using the Sirius Red F3B (SR) while the percentage of type I and III collagen in 3 groups were analyzed using the immunohistochemical staining. RESULTS: Compared with the normal group, the levels of TGF-β1, CTGF, CVF, type I and III collagen were higher in MI group. However, mRNA levels of TGF-β1 and CTGF were significantly decreased in MI + rhBNP compared to MI groups. Expression of TGF-β1 was lower while that of CTGF was higher in MI + rhBNP group than that in MI group. Besides, CVF, and type I and III collagen were lower in MI + rhBNP group compared with MI group. CONCLUSION: rhBNP could significantly decrease the TGF-β1 and CTGF levels in post-MI so as to inhibit the type I and III collagen deposition in MF of post-MI. rhBNP will be benefit for the improvement of MF.
PURPOSE: We aimed to observe the effects and mechanism of rhBNP treatment on myocardial fibrosis (MF) after myocardial infarction (MI). METHODS: SPF rats were separated into 3 groups: normal, MI (ligation of left coronary artery), and MI + rhBNP (recombinant human brain natriuretic peptide). Rats in MI + rhBNP group were given 30 μg/kg for 2 days before modeling and for 4 weeks after modeling. mRNA levels and the expression levels of TGF-β1 (transforming growth factor) and CTGF (connective tissue growth factor) in 3 groups were analyzed using the RT-qPCR and western blotting analysis, respectively. Furthermore, myocardial volume fraction (CVF) was analyzed using the Sirius Red F3B (SR) while the percentage of type I and III collagen in 3 groups were analyzed using the immunohistochemical staining. RESULTS: Compared with the normal group, the levels of TGF-β1, CTGF, CVF, type I and III collagen were higher in MI group. However, mRNA levels of TGF-β1 and CTGF were significantly decreased in MI + rhBNP compared to MI groups. Expression of TGF-β1 was lower while that of CTGF was higher in MI + rhBNP group than that in MI group. Besides, CVF, and type I and III collagen were lower in MI + rhBNP group compared with MI group. CONCLUSION:rhBNP could significantly decrease the TGF-β1 and CTGF levels in post-MI so as to inhibit the type I and III collagen deposition in MF of post-MI. rhBNP will be benefit for the improvement of MF.
Authors: Rachael G Dean; Leanne C Balding; Riccardo Candido; Wendy C Burns; Zemin Cao; Stephen M Twigg; Louise M Burrell Journal: J Histochem Cytochem Date: 2005-06-13 Impact factor: 2.479
Authors: Ellen A ten Brinke; Tomasz G Witkowski; Victoria Delgado; Patrick Klein; Margreet Klok; Nina A Marsan; Robert J Klautz; Ernst E van der Wall; Jeroen J Bax; Arnoud van der Laarse; Paul Steendijk Journal: Eur J Heart Fail Date: 2011-08-16 Impact factor: 15.534
Authors: Alberto Palazzuoli; Donald S Silverberg; Francesca Iovine; Anna Calabrò; Maria S Campagna; Maddalena Gallotta; Ranuccio Nuti Journal: Am Heart J Date: 2007-10 Impact factor: 4.749
Authors: Susana M Chuva de Sousa Lopes; Alie Feijen; Jeroen Korving; Olexander Korchynskyi; Jonas Larsson; Stefan Karlsson; Peter ten Dijke; Karen M Lyons; Roel Goldschmeding; Pieter Doevendans; Christine L Mummery Journal: Dev Dyn Date: 2004-11 Impact factor: 3.780